VELMENI Gets FDA 510(k) Clearance for 3D Dental Imaging Software

July 27, 2026
VELMENI has received FDA 510(k) clearance for VELMENI for DENTISTS 3D, software that uses AI to assist dental professionals with CBCT scan review and analysis.

VELMENI has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for VELMENI for DENTISTS 3D, announced in a press release. The software is designed to assist qualified dental professionals in reviewing and analyzing CBCT scans.

VELMENI for DENTISTS 3D includes AI assisted anatomical segmentation, visualization, measurements, panoramic reconstruction, and workflow support. It can help identify and segment structures such as the maxilla, mandible, mandibular canal, teeth, maxillary sinuses, temporomandibular joints, and airway structures.

The software also generates reconstructed panoramic and cross sectional views from CBCT datasets. Other features include 3D visualization, STL export for models, structured reporting, and connections to clinical documentation workflows.

VELMENI said the product is intended to assist dental professionals and does not replace a complete clinical examination, professional judgment, patient history, or patient assessment. Final diagnoses and treatment plans remain the responsibility of the treating dental professional.

We hope you enjoyed this article.

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Subscribe to Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Market report

2025 Generative AI in Professional Services Report

Thomson Reuters

This report by Thomson Reuters explores the integration and impact of generative AI technologies, such as ChatGPT and Microsoft Copilot, within the professional services sector. It highlights the growing adoption of GenAI tools across industries like legal, tax, accounting, and government, and discusses the challenges and opportunities these technologies present. The report also examines professionals' perceptions of GenAI and the need for strategic integration to maximize its value.

Read more